Lack of Diversity in Genetic Datasets is Risky for Treating Disease
Certain populations have been historically underrepresented in genome sequencing studies, but the NIH, private clinics, and 23andMe and other companies are trying to fix that.
Lack of Diversity in Genetic Datasets is Risky for Treating Disease
Lack of Diversity in Genetic Datasets is Risky for Treating Disease
Certain populations have been historically underrepresented in genome sequencing studies, but the NIH, private clinics, and 23andMe and other companies are trying to fix that.
Certain populations have been historically underrepresented in genome sequencing studies, but the NIH, private clinics, and 23andMe and other companies are trying to fix that.
Conceived as a way to resolve differences between government regulators and academics over the chemical’s effects, the CLARITY-BPA collaboration instead highlights divisions.
Exposure to bisphenol A or its alternative, bisphenol S, reduces the generation of new neurons in the embryonic animal’s hypothalamus, according to a small study.